
Pdax S 500mg/250mg Injection
Marketer
Pharma Drugs & Chemicals
Salt Composition
Ceftriaxone (500mg) + Sulbactam (250mg)
Overview Pdax S 500mg/250mg Injection
The combined antibacterial agent, Pdax S Injection (500mg/250mg), combats diverse bacterial infections by inhibiting microbial proliferation and spread. Administration must be solely under a doctor's guidance; adhere strictly to the prescribed schedule, completing the entire course regardless of symptom improvement. Premature cessation may compromise efficacy. Typical side effects include nausea, vomiting, diarrhea, and indigestion; worsening side effects necessitate immediate medical attention. Allergic reactions (rash, itching, swelling, dyspnea) demand immediate medical help. Inform your physician of all current medications before commencing treatment. Consult your doctor before use during pregnancy or breastfeeding. Alcohol should be avoided due to potential increased drowsiness. While generally not impairing driving ability, avoid driving if drowsiness or dizziness occur. Adequate rest, a balanced diet, and sufficient hydration are recommended for optimal recovery. Laboratory and diagnostic tests may be performed to monitor treatment response.
Uses of Pdax S 500mg/250mg Injection
Infections caused by bacteria
Major Benefits of Pdax S 500mg/250mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Pdax S 500mg/250mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Pdax S 500mg/250mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Pdax S 500mg/250mg Injection works:
Ceftriaxone and Sulbactam, the components of Pdax S 500mg/250mg Injection, act synergistically. Ceftriaxone, a cephalosporin antibiotic, disrupts bacterial cell wall synthesis, hindering their growth and survival. Sulbactam, a beta-lactamase inhibitor, counteracts bacterial resistance mechanisms, thereby improving Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with the concurrent use of alcohol and Pdax S 500mg/250mg Injection.
PregnancySAFE IF PRESCRIBED
The injectable medication Pdax S, 500mg/250mg, is typically deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or absent harm to offspring; nonetheless, data from human trials are scarce.
Breast feedingCAUTION
The administration of Pdax S 500mg/250mg Injection to breastfeeding mothers requires careful consideration. Mothers should discontinue breastfeeding throughout the course of treatment and until the medication is fully cleared from their system.
DrivingUNSAFE
The injection Pdax S 500mg/250mg can cause drowsiness, blurred vision, and dizziness. Refrain from driving if you experience these effects.
KidneyCONSULT YOUR DOCTOR
Data regarding the use of Pdax S 500mg/250mg Injection in individuals with renal impairment is scarce. Physician consultation is advised.
LiverCAUTION
Exercise caution when administering Pdax S 500mg/250mg Injection to individuals with severe hepatic impairment; dosage modification may be necessary. Seek medical advice. Dosage alteration for Pdax S 500mg/250mg Injection is unnecessary for patients exhibiting mild to moderate liver dysfunction.
What if you forget to take Pdax S 500mg/250mg Injection :
Omit a Pdax S 500mg/250mg Injection dose? Seek your physician's advice.
Facts to Know About Pdax S 500mg/250mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Antimicrobial Agents |
